NANOMEDICINE.ORG
  • Home
  • Nanomedicine Timeline
  • Journals
  • CLINAM history
  • Policy in Nanomedicine
  • Contact

CLINAM history
CLINAM - A Foundation, an international Network, a conference series, a birthplace of research consortia:
A lasting impact on the Nanomedicine field

Founders and Visionaries of CLINAM: Patrick Hunziker and Beat Löffler
Founding CLINAM Foundation
Initiating International Society of Nanomedicine
Creating the European Journal of Nanomedicine (now integrated into the Precision Nanomedicine Journal )

Dr. med. h.c. Beat Löffler, MA
  • Co-founder of CLINAM Foundation and Conference Series.
    CEO of CLINAM Foundation;
    Past secretary General of the International Society for Nanomedicine;
    Organizer of the CLINAM Summit.

    Key Contributions:
    • Architect of the annual CLINAM Summit and its international network
    • Responsible for programme content, organizational leadership, and dissemination
    • Strategic developer of European and global nanomedicine platforms
    • Advocate for clinician involvement and cross-disciplinary collaboration
    • A driver behind the creation of major European research projects
  • Prof. Dr. med. Patrick Hunziker (CLINAM Profile)
    Co-founder of CLINAM Foundation and CLINAM Conferences
    Chief Scientific Officer (CSO), of CLINAM Foundation and Scientific Chair of CLINAM ;
    President of the International Society for Nanomedicine;
    Deputy Chief of Intensive Care, University Hospital Basel.

    Key Contributions:
    • Shaping the scientific vision and contributing to the quality of CLINAM Summits
    • Leading the CLINAM Lab and Swissnano group
    • Advancing translational nanomedicine and clinical research
    • Instrumental in founding the European and International Societies for Nanomedicine
    • Major force in integrating clinicians into nanomedicine innovation

A few of the many major scientific figures and field leaders at CLINAM (also see Nobel laureates below)
  • Yechezkel Barenholz – Inventor of Doxil, pioneer in liposome research
  • Patrick Couvreur – Polymeric nanomedicines, drug delivery systems
  • Lou (Lajos) Balogh - Dentrimers
  • Twan Lammers – Tumor-targeted nanomedicine, imaging
  • Gert Storm – Nanocarriers for drug delivery
  • Dan Peer – RNA nanomedicine, targeted delivery
  • Claus-Michael Lehr – Mucosal nanomedicine, biological barriers
  • Donald A. Tomalia – Dendrimers.
  • Viola Vogel – Mechanobiology, biointerfaces
  • Dong Soo Lee – Molecular imaging, theranostics
  • Jan Mollenhauer – Cancer nanomedicine
  • Janos Szebeni – Immunotoxicology of nanomedicines
  • Scott McNeil – Regulatory science, nanopharmaceuticals
  • Peter Wick – Nanoparticle safety, regulatory science
  • Ruth Schmid – Polymer nanoparticles, industrial translation
  • Marisa Papaluca Amati – Regulatory frameworks for nanomedicines
  • Jon de Vlieger – NBCDs, regulatory science
  • Liangfang Zhang – Biomimetic nanoparticles, cell-membrane coatings
  • Katalin Karikó – mRNA technology

Nobel Laureates Who Have contributed to the field and presented at CLINAM
including Nobel Prize Year and Field, presenting at CLINAM in specific years.
  • Werner Arber  1978  Medicine. Discovery of restriction enzymes 2011, 2012, 2013
  • Aaron Ciechanover 2004 Chemistry. Ubiquitin-mediated protein degradation 2016, 2018
  • Jean-Marie Lehn 1987 Chemistry. Supramolecular chemistry 2017, 2018
  • Ada Yonath 2009 Chemistry. Ribosome structure, antibiotics 2015, 2022, 2023
  • Gerd Binnig 1986 Physics. Scanning tunneling microscopy 2015
  • Susumu Tonegawa 1987 Medicine. Genetic principle for antibody diversity 2015
  • Richard J. Roberts 1993 Medicine. DNA methylation, restriction enzymes 2014
  • Kurt Wüthrich 2002 Chemistry. NMR structure determination of biological macromolecules 2014
  • Harald zur Hausen 2008 Medicine. HPV and cervical cancer 2013
  • Jack W. Szostak 2009 Medicine. Telomeres and telomerase 2013
  • Rolf Zinkernagel 1996 Medicine. Discovery of immune recognition of virus-infected cells 2012
  • Sir Harold Kroto 1996 Chemistry. Fullerenes (buckyballs), nanocarbon 2011
  • Françoise Barré-Sinoussi 2008. Medicine Discovery of HIV 2015
  • Luc Montagnier 2008 Medicine. Discovery of HIV 2012
  • Paul L. Modrich 2015 Chemistry. DNA repair 2020
  • Drew Weissman 2023 Medicine. mRNA vaccine technology 2023

CLINAM’s Historic Impact and Unique Role
  • Scientific impact: Presenters include the most cited and influential minds in nanomedicine, drug delivery, and translational science.
  • Foundational leadership: Beat Löffler and Patrick Hunziker have shaped the field’s global dialogue, uniting clinicians, researchers, industry, and regulators for over 15 years.
  • Interdisciplinary reach: CLINAM a neutral, nonprofit platform accelerating innovation and clinical translation in nanomedicine.
  • Nobel laureate participation at nearly every summit, spanning chemistry, physics, and medicine, deepening and widening the impact of the field.

CLINAM's Role in Global Convergence of Regulatory Science and Education
The CLINAM (European and Global Summit for Clinical Nanomedicine) Summits have significantly influenced the global regulatory science landscape of nanomedicine. Here is a concise overview of their key contributions:(ResearchGate)
  • Global Regulatory Convergence: CLINAM Summits have provided a unique platform where regulatory authorities from all continents convene annually to discuss the needs of stakeholders in nanomedicine. This has facilitated global regulatory convergence and harmonization efforts in the field. (projects.leitat.org)
  • Catalyst for Regulatory Framework Development: The Summits have played a pivotal role in initiating discussions and collaborations that have led to the development of regulatory frameworks for nanomedicine, addressing the unique challenges posed by nanotechnology-enabled health products. (PMC)
  • Promotion of Interdisciplinary Collaboration: By bringing together scientists, clinicians, industry representatives, and regulators, CLINAM has fostered interdisciplinary collaboration essential for the advancement of regulatory science in nanomedicine.
  • Educational Impact: The Summits have served as educational platforms, disseminating knowledge on the latest developments in nanomedicine and its regulatory aspects, thus contributing to the capacity building of stakeholders worldwide.
  • Influence on Policy and Standards: Discussions and outcomes from CLINAM Summits have informed policy-making and the establishment of standards, influencing the regulatory landscape of nanomedicine globally. (PMC)
For more detailed information, you can visit the official CLINAM website: https://clinam.org/

For the full annual presenter lists and further details, see the CLINAM Conference Archives.

  • Home
  • Nanomedicine Timeline
  • Journals
  • CLINAM history
  • Policy in Nanomedicine
  • Contact